Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Braz J Biol ; 75(4 Suppl 2): S53-61, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26628242

RESUMEN

The advanced oxidation process (AOP) is used to increase the treatment efficiency of effluents however, it is necessary to compare the toxicity of treated and untreated effluents to evaluate if the decontamination process does not cause any biological harm. Cultured cells have been previously used to assess the genotoxic and cytotoxic potential of various compounds. Hence, the aim of this work was to assess the applicability of cytotoxicity assays to evaluate the toxicity related to the AOP treatment. Samples of an industrial effluent were collected after their treatment by a conventional method. Cytotoxicity of standard and AOP treated effluents was assessed in CRIB and HEp-2 cell line using the MTT and neutral red assays. We observed decrease at cell viability in the both assays (50% MTT and 13% NRU) when cells were exposed to the AOP treatment in the highest concentration. Thus, cytotoxic assays in cultured cells can be explored as an useful method to evaluate toxicity as well as to optimize effluents treatment process.


Asunto(s)
Citotoxinas/toxicidad , Fotólisis , Aguas Residuales/toxicidad , Contaminantes Químicos del Agua/toxicidad , Animales , Bovinos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Técnicas Electroquímicas , Humanos , Residuos Industriales/análisis , Oxidación-Reducción , Curtiembre , Pruebas de Toxicidad
2.
Braz. j. biol ; 75(4,supl.2): 53-61, Dec. 2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-769601

RESUMEN

The advanced oxidation process (AOP) is used to increase the treatment efficiency of effluents however, it is necessary to compare the toxicity of treated and untreated effluents to evaluate if the decontamination process does not cause any biological harm. Cultured cells have been previously used to assess the genotoxic and cytotoxic potential of various compounds. Hence, the aim of this work was to assess the applicability of cytotoxicity assays to evaluate the toxicity related to the AOP treatment. Samples of an industrial effluent were collected after their treatment by a conventional method. Cytotoxicity of standard and AOP treated effluents was assessed in CRIB and HEp-2 cell line using the MTT and neutral red assays. We observed decrease at cell viability in the both assays (50% MTT and 13% NRU) when cells were exposed to the AOP treatment in the highest concentration. Thus, cytotoxic assays in cultured cells can be explored as an useful method to evaluate toxicity as well as to optimize effluents treatment process.


Resumo O processo de oxidação avançada (POA) tem sido usado para aumentar a eficiência do tratamento de efluentes; no entanto, é necessário comparar a toxicidade de efluentes tratados e não tratados para avaliar se o processo de descontaminação não é capaz de causar algum risco biológico. Cultivos celulares têm sido utilizados para avaliar o potencial genotóxico e citotóxico de vários compostos. Assim, o objetivo deste trabalho foi avaliar a aplicabilidade de ensaios de citotoxicidade para avaliar a toxicidade relacionada ao tratamento com POA. As amostras de um efluente industrial foram recolhidas após o tratamento por um método convencional. A citotoxicidade dos efluentes padrão e tratado com POA foi avaliada nas linhagens celulares CRIB e HEp-2 usando os ensaios do MTT e do vermelho neutro. Observou-se diminuição da viabilidade celular em ambos os ensaios (50% MTT e 13% VN) quando as células foram expostas à concentração mais elevada do efluente tratado com POA. Assim, os ensaios de citotoxicidade em cultivos celulares podem ser explorados como um método útil para avaliar a toxicidade, bem como para otimizar os processos de tratamento de efluentes.


Asunto(s)
Animales , Bovinos , Humanos , Citotoxinas/toxicidad , Fotólisis , Aguas Residuales/toxicidad , Contaminantes Químicos del Agua/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Técnicas Electroquímicas , Residuos Industriales/análisis , Oxidación-Reducción , Curtiembre , Pruebas de Toxicidad
3.
Braz. j. biol ; 75(4)Nov. 2015.
Artículo en Inglés | LILACS-Express | LILACS, VETINDEX | ID: biblio-1468358

RESUMEN

The advanced oxidation process (AOP) is used to increase the treatment efficiency of effluents however, it is necessary to compare the toxicity of treated and untreated effluents to evaluate if the decontamination process does not cause any biological harm. Cultured cells have been previously used to assess the genotoxic and cytotoxic potential of various compounds. Hence, the aim of this work was to assess the applicability of cytotoxicity assays to evaluate the toxicity related to the AOP treatment. Samples of an industrial effluent were collected after their treatment by a conventional method. Cytotoxicity of standard and AOP treated effluents was assessed in CRIB and HEp-2 cell line using the MTT and neutral red assays. We observed decrease at cell viability in the both assays (50% MTT and 13% NRU) when cells were exposed to the AOP treatment in the highest concentration. Thus, cytotoxic assays in cultured cells can be explored as an useful method to evaluate toxicity as well as to optimize effluents treatment process.


Resumo O processo de oxidação avançada (POA) tem sido usado para aumentar a eficiência do tratamento de efluentes; no entanto, é necessário comparar a toxicidade de efluentes tratados e não tratados para avaliar se o processo de descontaminação não é capaz de causar algum risco biológico. Cultivos celulares têm sido utilizados para avaliar o potencial genotóxico e citotóxico de vários compostos. Assim, o objetivo deste trabalho foi avaliar a aplicabilidade de ensaios de citotoxicidade para avaliar a toxicidade relacionada ao tratamento com POA. As amostras de um efluente industrial foram recolhidas após o tratamento por um método convencional. A citotoxicidade dos efluentes padrão e tratado com POA foi avaliada nas linhagens celulares CRIB e HEp-2 usando os ensaios do MTT e do vermelho neutro. Observou-se diminuição da viabilidade celular em ambos os ensaios (50% MTT e 13% VN) quando as células foram expostas à concentração mais elevada do efluente tratado com POA. Assim, os ensaios de citotoxicidade em cultivos celulares podem ser explorados como um método útil para avaliar a toxicidade, bem como para otimizar os processos de tratamento de efluentes.

4.
J Neurosci ; 21(24): 9888-95, 2001 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-11739596

RESUMEN

Intrabrain transplantation of chromaffin cell aggregates of the Zuckerkandl's organ, an extra-adrenal paraganglion that has never been tested for antiparkinsonian treatment, induced gradual improvement of functional deficits in parkinsonian rats. These beneficial effects were related to long survival of grafted cells, striatal reinnervation, and enhancement of dopamine levels in grafted striatum. Grafted cells were not dopaminergics, but they expressed glial cell line-derived neurotrophic factor (GDNF) and transforming growth factor-beta(1). These factors were detected in the host striatal tissue, indicating that chromaffin cells secreted them after grafting. Because glial cell line-derived neurotrophic factor possesses neurorestorative properties over dopaminergic neurons, and transforming growth factor-beta(1) is a cofactor that potentiates the neurotrophic actions of GDNF, functional regeneration was likely caused by the chronic trophic action of neurotrophic factors delivered by long-surviving grafted cells. This work should stimulate research on the clinical applicability of transplants of the Zuckerkandl's organ in Parkinson's disease.


Asunto(s)
Células Cromafines/trasplante , Factores de Crecimiento Nervioso , Proteínas del Tejido Nervioso/biosíntesis , Enfermedad de Parkinson Secundaria/terapia , Regeneración/fisiología , Sustancia Negra/cirugía , Factor de Crecimiento Transformador beta/biosíntesis , Médula Suprarrenal/citología , Médula Suprarrenal/trasplante , Animales , Trasplante de Células , Células Cromafines/metabolismo , Cuerpo Estriado/química , Cuerpo Estriado/metabolismo , Cuerpo Estriado/patología , Modelos Animales de Enfermedad , Dopamina/metabolismo , Expresión Génica , Factor Neurotrófico Derivado de la Línea Celular Glial , Supervivencia de Injerto , Actividad Motora , Proteínas del Tejido Nervioso/análisis , Oxidopamina , Cuerpos Paraaórticos/citología , Cuerpos Paraaórticos/trasplante , Enfermedad de Parkinson Secundaria/inducido químicamente , Enfermedad de Parkinson Secundaria/patología , Ratas , Ratas Wistar , Recuperación de la Función , Sustancia Negra/metabolismo , Sustancia Negra/patología , Transmisión Sináptica , Factor de Crecimiento Transformador beta/análisis , Factor de Crecimiento Transformador beta1 , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA